Data gathered: September 17
Alternative Data for RedHill Biopharma
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 56 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| Patents | 38 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 7,306 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,378 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 36 | Sign up | Sign up | Sign up |
| Linkedin Employees | 48 | Sign up | Sign up | Sign up |
About RedHill Biopharma
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
| Price | $1.70 |
| Target Price | Sign up |
| Volume | 124,960 |
| Market Cap | $5M |
| Year Range | $1.16 - $6.59 |
| Dividend Yield | 0% |
| PE Ratio | 0 |
| Analyst Rating | 0% buy |
| Industry | Drug Manufacturers |
In the news
 |
Critical Contrast: Larimar Therapeutics (NASDAQ:LRMR) & Redhill Biopharma (NASDAQ:RDHL)September 17 - ETF Daily News |
 |
Redhill Biopharma (NASDAQ:RDHL) and Cumberland Pharmaceuticals (NASDAQ:CPIX) Head to Head SurveySeptember 7 - ETF Daily News |
|
Redhill Biopharma (NASDAQ:RDHL) Stock Price Passes Below 200 Day Moving Average – Should You Sell?August 22 - ETF Daily News |
Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsightSeptember 4 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 2.7M | 890,000 | 1.8M | -2.6M | -1.9M | -4.020 |
| Q4 '24 | 0 | 0 | 0 | 0 | 0 | -4.020 |
| Q3 '24 | 2.7M | 890,000 | 1.8M | -2.6M | -1.8M | 0.000 |
| Q2 '24 | 1.3M | 700,000 | 580,000 | -1.5M | -4M | -200.000 |
| Q1 '24 | 1.3M | 700,000 | 580,000 | -1.5M | -4M | -0.200 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$177.2 0.4% | 41 |
 |
Eli Lilly and CompanyLLY |
$760.13 0.6% | 78 |
 |
PfizerPFE |
$24.05 0.6% | 51 |
 |
AstrazenecaAZN |
$77.69 0.2% | 51 |
 |
AbbVieABBV |
$220.81 2.1% | 58 |
Read more about RedHill Biopharma (RDHL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of RedHill Biopharma?
The Market Cap of RedHill Biopharma is $5M.
What is RedHill Biopharma's PE Ratio?
As of today, RedHill Biopharma's PE (Price to Earnings) ratio is 0.
What is the current stock price of RedHill Biopharma?
Currently, the price of one share of RedHill Biopharma stock is $1.70.
How can I analyze the RDHL stock price chart for investment decisions?
The RDHL stock price chart above provides a comprehensive visual representation of RedHill Biopharma's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling RedHill Biopharma shares. Our platform offers an up-to-date RDHL stock price chart, along with technical data analysis and alternative data insights.
Does RDHL offer dividends to its shareholders?
As of our latest update, RedHill Biopharma (RDHL) does not offer dividends to its shareholders. Investors interested in RedHill Biopharma should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of RedHill Biopharma?
Some of the similar stocks of RedHill Biopharma are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.